HCATHealth Catalyst Inc
$1.64
$0.04
(2.50%)
Closed $1.64
$0.06
(3.66%)
After Hours
EarningsAug 6
Mkt Cap$118.23M
Vol2.39M
Fundamentals
Mkt Cap
$118.23M
Volume
-
52W High
$4.13
52W Low
$0.9551
PE Ratio
-0.44
Avg. Volume
599,862.97
EPS (Annual)
-$2.55
Rev/Employee
$259,280.00
Earnings
Aug 06
38
Bearish Sentiment
How do you feel about HCAT?
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield PR Newswire PARSIPPANY, N.J., June 4, 2026 PARSIPPANY, N.J., June 4...
PR Newswire
Health Catalyst (HCAT) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Health Catalyst (HCAT) Q1 Earnings and Revenues Surpass Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of +300.00% and +2.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Seeking Clues to Health Catalyst (HCAT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Health Catalyst (HCAT) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Zacks
Privia Health (PRVA) Misses Q1 Earnings Estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -76.19% and +7.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have received a consensus rating of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold...
MarketBeat
Health Catalyst (HCAT) to Release Quarterly Earnings on Wednesday
Health Catalyst (NASDAQ:HCAT) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-health-catalyst-inc-stock...
MarketBeat
American Well (AMWL) Surges 13.3%: Is This an Indication of Further Gains?
American Well (AMWL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Brokerages
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has earned an average recommendation of "Hold" from the thirteen analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation a...
MarketBeat
<
1
2
...
>